Bencherif Receives DFCI/NU Joint Program Grant
ChE Assistant Professor Sidi Bencherif recently won the Dana-Farber Cancer Institute/Northeastern University Joint Program in Cancer Drug Development award. DFCI and Northeastern believe that projects that combine their two unique approaches to their organization’s missions are likely to have “rapid and high impact effects on the cancer problem.”
Professor Bencherif is working in collaboration with Dr. Leigh Ellis from DFCI on a project titled “Cryogel-based tumor cell vaccines for prostate cancer”. They state that cancer is essentially incurable once it becomes metastatic and success in the development of a therapeutic vaccine would have a dramatic impact on the lives of millions of patients and their families. Prof. Bencherif and Dr. Ellis have been actively interacting and are welcoming the opportunity to join forces due to their unique complimentary expertise to develop a potent and durable biomaterial – based whole tumor cell vaccine that can be used to treat men suffering from advanced prostate cancer.